Correction: Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
James C. Scott, Neha Shah, Travis Porco, Jennifer Flood
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical Economics and Policy · Tuberculosis Research and Epidemiology · Biosimilars and Bioanalytical Methods
The Funding section is incorrect. The complete, correct Funding statement is: TCP acknowledges support of the MIDAS study NIH NIGMS U01-GM087728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The reference list from the paper itself. Each links out to its DOI / PubMed record.